  Leishmania lipophosphoglycan is a molecule that has been used as a vaccine
candidate, with contradictory results. Since unsuccessful protection could be
related to suppressed T cell responses, we analyzed the expression of
inhibitory receptor PD-1 in CD8+ and CD4+ lymphocytes and it is ligand PD-L2 in
macrophages of BALB/c mice immunized with various doses of Leishmania mexicana
LPG and re-stimulated in vitro with different concentrations of LPG.
Vaccination with LPG enhanced the expression of PD-1 in CD8+ cells. Activation
molecules CD137 were reduced in CD8+ cells from vaccinated mice. In vitro
re-stimulation enhanced PD-L2 expression in macrophages of healthy mice in a
dose-dependent fashion. The expression of PD-1, PD-L2, and CD137 is modulated
according to the amount of LPG used during immunization and in vitro
re-stimulation. We analyzed the expression of these molecules in mice infected
with 1 x 10'4 or 1 x 10'5 L. mexicana promastigotes and re-stimulated in vitro
with LPG. Infection with 1 x 10'5 parasites increased the PD-1 expression in
CD8+ and diminished PD-L2 in macrophages. When these CD8+ cells were
re-stimulated in vitro with LPG, simulating a second exposure to parasite
antigens, PD-1 expression increased significantly more, in a dose-dependent
fashion. We conclude that CD8+ T lymphocytes and macrophages express inhibition
molecules according to the concentrations of Leishmania LPG and to the parasite
load. Vaccination with increased amounts of LPG or infections with higher
parasite numbers induces enhanced expression of PD-1 and functional
inactivation of CD8+ cells, which can have critical consequences in
leishmaniasis since these cells are crucial for disease control.
